Item 1.01 Entry into a Material Definitive Agreement

Hospira, Inc. ("Hospira") entered into an Underwriting Agreement, dated as of May 5, 2009 (the "Underwriting Agreement"), by and between Hospira and Banc of America Securities LLC and Morgan Stanley & Co. Incorporated, as managers of the several underwriters named in Schedule II to the Underwriting Agreement (the "Underwriters"), pursuant to which Hospira has agreed to issue to the Underwriters $250,000,000 aggregate principal amount of its 6.400% Notes due May 15, 2015 (the "Notes"). The Underwriting Agreement contains customary indemnification provisions. The Notes are subject to the Registration Statement on Form S-3 (File No. 333-158939) that Hospira filed with the Securities and Exchange Commission (the "SEC") on May 1, 2009 relating to the public offering from time to time of debt securities of Hospira pursuant to Rule 415 of the Securities Act of 1933, as amended. In connection with Hospira's filing with the SEC of a definitive prospectus supplement, dated May 5, 2009, and prospectus, dated May 1, 2009, relating to the public offering of the Notes, Hospira is filing certain exhibits as part of this Current Report on Form 8-K. See "Item
9.01 - Financial Statements and Exhibits."

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

A list of exhibits filed herewith is contained on the Exhibit Index immediately preceding such exhibits and is incorporated herein by reference.

---